Maria Soriano
Group President of Infusion Therapies & PlatformsMs. Maria Soriano, also known as Cecilia, is Group President, Infusion Therapies since December 1, 2025 & was Group President of Technologies & Pharmaceuticals at Baxter International Inc. since December 1, 2025 until April 2026 and is Group President of Platforms since April 2026. Ms. Soriano was appointed to her expanded role in 2025 after serving as president of Infusion Therapies and Technologies since joining Baxter in 2023. Ms. Soriano brings nearly 30 years of experience across medical device and pharmaceutical businesses to Baxter, having previously served as global vice president/general manager of microbiology at Becton Dickinson (BD) in addition to holding several roles across marketing, commercial and business leadership at both BD and Johnson & Johnson. Soriano serves as a member of the board of ScionHealth, a national healthcare system. She received her bachelor's degree in business administration from Universidad Belgrano in Buenos Aires, Argentina and an MBA from the Pamplin School of Business at Virginia Tech University.
公司職務
- 公司名稱Baxter International Inc.股票代碼BAX職務Group President of Infusion Therapies & Platforms共事同僚
- APAndrew P. HiderCEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director
- DBDavid Brent ShaferIndependent Chairman of the Board
- DSDavid S. RosenbloomExecutive VP & General Counsel
- JTJohn Terence RogersExecutive VP & CFO
- BHBernie HeineInterim Chief Accounting Officer & Controller
- PBPatricia B. MorrisonIndependent Director
- NMNancy M. SchlichtingIndependent Director
- WAWilliam A. AmpofoIndependent Director
